Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance-Reference-Cited by-同舟云学术

Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance

Published:2015-12 Issue:1 Volume:496 Page:137-156
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Fule Ritesh,Dhamecha Dinesh,Maniruzzaman Mohammed,Khale Anubha,Amin Purnima

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference47 articles.

1. Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions;Andrews;J. Pharm. Pharmacol.,2010

2. Physical and chemical stability of expired fixed dose combination artemether–lumefantrine in uncontrolled tropical conditions;Bate;Malar. J.,2009

3. Melt extrusion: from process to drug delivery technology;Breitenbach;Eur. J. Pharm. Biopharm.,2002

4. Simultaneous determination of artemether and lumefantrine in fixed dose combination tablets by HPLC with UV detection;Costa César;J. Pharm. Biomed. Anal.,2008

5. Co-extrusion as manufacturing technique for fixed-dose combination mini-matrices;Dierickx;Eur. J. Pharm. Biopharm.,2012

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the effect of protein secondary structure on the solid state and physical stability of protein-based amorphous solid dispersions;European Journal of Pharmaceutics and Biopharmaceutics;2024-05

2. Herbal based nanoemulsions in psoriasis therapy: A review;Pharmacological Research - Natural Products;2024-03

3. Self-Emulsifying Drug Delivery System for Enhanced Oral Delivery of Tenofovir: Formulation, Physicochemical Characterization, and Bioavailability Assessment;ACS Omega;2024-02-03

4. Exploring the Effect of Protein Secondary Structure on the Solid State and Physical Stability of Protein-Based Amorphous Solid Dispersions;2024

5. Solubility-enabling formulations for oral delivery of lipophilic drugs: considering the solubility-permeability interplay for accelerated formulation development;Expert Opinion on Drug Delivery;2023-12-29